- |||||||||| Enrollment change, Trial termination, Trial primary completion date, IO biomarker: Consequences of Anti-interleukin 6 Immunotherapy Treatment for Rheumatoid Arthritis on Periodontium (clinicaltrials.gov) - Nov 10, 2015
P4, N=16, Terminated, Initiation date: Aug 2009 --> Jan 2009 N=47 --> 16 | Recruiting --> Terminated | Trial primary completion date: Sep 2015 --> Jun 2015; as the recruitment rate was very low, a futility study was conducted and it was decided to discontinue inclusions
- |||||||||| Humira (adalimumab) / Eisai, AbbVie
Trial primary completion date, Adherence: Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice (clinicaltrials.gov) - Nov 9, 2015 P=N/A, N=140, Recruiting, Active, not recruiting --> Completed Trial primary completion date: Jul 2016 --> Mar 2017
- |||||||||| Orencia (abatacept) / BMS
Enrollment change: Methotrexate-Inadequate Response Study (clinicaltrials.gov) - Nov 9, 2015 P3, N=2492, Completed, Trial primary completion date: Jul 2016 --> Mar 2017 N=1482 --> 2492
- |||||||||| Trial completion, Trial primary completion date: Hybrid Artificial Pancreas in Home Setting (clinicaltrials.gov) - Nov 8, 2015
P2, N=36, Completed, Not yet recruiting --> Recruiting Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Jun 2015
- |||||||||| BioChaperone glargine/lispro (insulin glargine/insulin lispro) / Adocia
Trial completion: Postprandial Blood Glucose Control With BioChaperone (clinicaltrials.gov) - Nov 8, 2015 P1, N=28, Completed, Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Jun 2015 Recruiting --> Completed
- |||||||||| Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
Enrollment open, Trial primary completion date: Long-term Immunogenicity of a HPV Vaccine in SLE (clinicaltrials.gov) - Nov 5, 2015 P=N/A, N=100, Recruiting, Recruiting --> Terminated; Lack of funding Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2015 --> Mar 2016
- |||||||||| Lantus (insulin glargine) / Sanofi, Lusduna (insulin glargine biosimilar) / Samsung
Trial initiation date: A Study of the Safety and Efficacy of MK-1293 Compared to Lantus (clinicaltrials.gov) - Nov 5, 2015 P3, N=500, Active, not recruiting, Active, not recruiting --> Terminated | Trial primary completion date: Oct 2015 --> Jan 2016; This study terminated on April 8, 2015 due to a corporate decision and not related to the safety or efficacy of the protocol. Initiation date: Feb 2014 --> Oct 2013
- |||||||||| Trial termination, Trial primary completion date: An ACT Based Application for Young People With Type 1 Diabetes (clinicaltrials.gov) - Nov 3, 2015
P=N/A, N=116, Terminated, Initiation date: Feb 2014 --> Oct 2013 Recruiting --> Terminated | Trial primary completion date: Apr 2016 --> Nov 2015; No uptake from potential participants
|